Status:

COMPLETED

Diagnostic Rentability of Screening for Associated Conditions in Calcium Pyrophosphate Deposition Disease Patients

Lead Sponsor:

Sociedade Galega de Reumatoloxía

Conditions:

Chondrocalcinosis

Eligibility:

All Genders

Brief Summary

The purpose of this study is to determine whether thorough analytical evaluation is useful to diagnose metabolic conditions associated to calcium pyrophosphate deposition disease.

Detailed Description

The diagnostic usefulness of screening for hyperparathyroidism, hemochromatosis, hypothyroidism and hypophosphatasia in patients diagnosed with calcium pyrophosphate dihydrate (CPPD) deposition diseas...

Eligibility Criteria

Inclusion

  • Patients diagnosed as having calcium pyrophosphate dihydrate deposition disease.

Exclusion

  • Patients mimicking a rheumatoid arthritis disease, with positive rheumatoid factor or with psoriasis.

Key Trial Info

Start Date :

January 1 1997

Trial Type :

OBSERVATIONAL

End Date :

December 1 2006

Estimated Enrollment :

240 Patients enrolled

Trial Details

Trial ID

NCT00453128

Start Date

January 1 1997

End Date

December 1 2006

Last Update

March 28 2007

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Meixoeiro Hospital

Vigo, Pontevedra, Spain, 36214